E

Even One Ventures

Venture capital funding personalized therapeutics

Overview

Even One Ventures is a venture capital firm that funds early-stage life sciences companies developing personalized therapies for life-threatening diseases. It operates with a patient-first investment approach, concentrating on pre-seed to Series B rounds to accelerate the development of medicines that may not otherwise exist. By investing across biotech and healthcare areas such as oncology, immune health, women’s health, rare diseases, and longevity, it supports teams from discovery to clinical development and commercialization. The firm differentiates itself by focusing on personalized, patient-tailored approaches and by building a portfolio that includes immune profiling, rescued oncology assets, personalized mRNA cancer vaccines, and custom T-cell therapies. Its goal is to get scientific advances quickly to patients, giving future patients a head start through ventures formed from the founder’s own health journey and deep scientific collaboration.

Work here?Claim your company

About Even One Ventures

Simplify's Rating
Why Even One Ventures is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Venture CapitalBiotechnologyHealthcare

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2025

Get referred to Even One Ventures

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • The website was updated October 29, 2026, showing active company creation and expansion.
  • Jiyu Bio launched by November 10, 2026, showing continued portfolio formation.
  • Arden Bio and Echo Immune give EOV multiple shots at defensible precision-medicine winners.

What critics are saying

  • Echo Immune has no published trials; the platform thesis remains unproven clinically.
  • Most portfolio companies are startup-stage, so exits depend on years of preclinical execution.
  • If personalized therapeutics miss efficacy or reimbursement, Even One Ventures becomes a story-driven experiment, not a durable firm.

What makes Even One Ventures unique

  • Sid Sijbrandij’s cancer journey drives a patient-first venture studio, not a passive fund.
  • EOV builds companies around individualized diagnostics, vaccines, TCRs, and rare-disease therapies.
  • Its 2026 portfolio spans oncology, immune disease, women’s health, longevity, and China trial access.

Help us improve and share your feedback! Did you find this helpful?

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Even One Ventures right now.

Find jobs on Simplify and start your career today

We update Even One Ventures's jobs every few hours, so check again soon!Browse all jobs